Related Articles
Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway
Visnagin: A novel cardioprotective agent against anthracycline toxicity (Review)
Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells
Crosstalk between autophagy and intracellular radiation response (Review)
Potential intervention target of atherosclerosis: Ferroptosis (Review)